Evidence map›Paper›PMID 28976945›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Activation of Nigrostriatal Dopamine Neurons during Fear Extinction Prevents the Renewal of Fear.

Courtney A Bouchet, Megan A Miner, Esteban C Loetz, Adam J Rosberg, Holly S Hake, Caroline E Farmer, Mykola Ostrovskyy, Nathan Gray, Benjamin N Greenwood

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Threat and Bidirectional Valence Signaling in the Nucleus Accumbens Core.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Courtney A BouchetDepartment of Psychology, University of Colorado, Denver, CO, USA.
Megan A MinerDepartment of Psychology, University of Colorado, Denver, CO, USA.
Esteban C LoetzDepartment of Psychology, University of Colorado, Denver, CO, USA.
Adam J RosbergDepartment of Psychology, University of Colorado, Denver, CO, USA.
Holly S HakeDepartment of Psychology, University of Colorado, Denver, CO, USA.
Caroline E FarmerDepartment of Psychology, University of Colorado, Denver, CO, USA.
Mykola Ostrovskyy
Nathan Gray
Benjamin N GreenwoodDepartment of Psychology, University of Colorado, Denver, CO, USA.
University of Colorado Denver · US

Funding

Nigrostriatal Dopaminergic Modulation of Fear ExtinctionR15MH114026 · NIMH · UNIVERSITY OF COLORADO DENVER · PI GREENWOOD, BEN N · 2017 to 2020
$933k
NIMH NIH HHS R15 MH114026
6 · The paper itself

Abstract

Manipulations that increase dopamine (DA) signaling can enhance fear extinction, but the circuits involved remain unknown. DA neurons originating in the substantia nigra (SN) projecting to the dorsal striatum (DS) are traditionally viewed in the context of motor behavior, but growing data implicate this nigrostriatal circuit in emotion. Here we investigated the role of nigrostriatal DA in fear extinction. Activation of SN DA neurons with designer G

Indexed as

AnimalsAuditory PerceptionCorpus StriatumDopaminergic NeuronsExtinction, PsychologicalFearMaleMemoryNucleus AccumbensProto-Oncogene Proteins c-fosRats, Long-EvansRats, TransgenicReceptors, Dopamine D1Receptors, Dopamine D2RNA, MessengerSubstantia NigraDRD2 protein, ratProto-Oncogene Proteins c-fosReceptors, Dopamine D1Receptors, Dopamine D2RNA, Messenger

Identifiers

PMID28976945
PMCPMC5770770
OpenAlexW2763129795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.